Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity

The molecular chaperone Heat shock protein 90 (Hsp90) is essential for the folding, stability, and activity of several drivers of oncogenesis. Hsp90 inhibitors are currently under clinical evaluation for cancer treatment, however their efficacy is limited by lack of biomarkers to optimize patient se...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodford, Mark R., Hughes, Michael, Sager, Rebecca A., Backe, Sarah J., Baker-Williams, Alexander J., Bratslavsky, Michael S., Jacob, Joseph M., Shapiro, Oleg, Wong, Michael, Bratslavsky, Gennady, Bourboulia, Dimitra, Mollapour, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791385/
https://www.ncbi.nlm.nih.gov/pubmed/31645902
http://dx.doi.org/10.18632/oncotarget.27217

Ejemplares similares

Ejemplares similares